Pharmaceutical Technology checked in with AAPS and IPEC-Americas to get an update on how the organizations are navigating the pandemic and planning for the future.
LEOWOLFERT - STOCK.ADOBE.COM
Pharmaceutical development, manufacturing, and quality efforts are often advanced by the work of industry associations and members through conferences, training sessions, publications, and working groups. These efforts continued during the past 18 months, despite restrictions posed by the COVID-19 pandemic. The American Association of Pharmaceutical Scientists (AAPS) and the International Pharmaceutical Excipients Council of the Americas (IPEC-Americas) shared recent activities and industry contributions with Pharmaceutical Technology.Read in this article in Pharmaceutical Technology’s September 2021 Regulatory Sourcebook eBook.
Read in this article in Pharmaceutical Technology’s September 2021 Regulatory Sourcebook eBook.
Pharmaceutical Technology
eBook: Regulatory Sourcebook
September 2021
Pages: 42-45
When referring to this article, please cite it as PharmTech Editors, “Industry Organizations Assist Pharma During the Pandemic and Beyond,” Pharmaceutical Technology’s Regulatory Sourcebook eBook (September 2021).
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
A Novel, Enhanced, and Sustainable Approach to Audit Trail Review
July 4th 2025Eli Lilly and Company developed an innovative and sustainable approach to audit trail review (ATR) aimed at reducing the ATR burden while adhering to regulatory expectations and data integrity (DI) principles. The process has transformed employees' understanding of ATR and complemented the DI by design approach, leading to better system designs that meet expected controls and reduce non-value-added data reviews.